The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells

Breast Cancer Research

Volumn 11, Issue 5, 2009, Pages

  Workman, Heather C ^a   Miller, Jamie K ^a   Ingalla, Ellen Q ^a   Kaur, Rouminder P ^a   Yamamoto, Diane I ^b   Beckett, Laurel A ^b   Young, Lawrence J T ^c   Cardiff, Robert D ^c   Borowsky, Alexander D ^c   Carraway, Kermit L ^d   Sweeney, Colleen ^a   Carraway III, Kermit L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1G8; MUCIN 4; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; MUC4 PROTEIN, HUMAN;

ANIMAL CELL; ANOIKIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL LYSATE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MALIGNANT TRANSFORMATION; NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TISSUE MICROARRAY; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; CHEMISTRY; FEMALE; IMMUNOLOGY; LYMPH NODE; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; PLEURA TUMOR; TUMOR CELL LINE;

ANOIKIS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MUCIN-4; PLEURAL NEOPLASMS;

EID: 77449120727     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2364     Document Type: Article

References (43)

1. Strous GJ, Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992, 27:57-92. 10.3109/10409239209082559, 1727693.
2. Zhang J, Perez A, Yasin M, Soto P, Rong M, Theodoropoulos G, Carothers Carraway CA, Carraway KL. Presence of MUC4 in human milk and at the luminal surfaces of blood vessels. J Cell Physiol 2005, 204:166-177. 10.1002/jcp.20277, 15672420.
3. Zhang J, Carraway CA, Carraway KL. Muc4 expression during blood vessel formation in damaged rat cornea. Curr Eye Res 2006, 31:1011-1014. 10.1080/02713680601052155, 17169838.
4. Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem 1999, 274:31751-31754. 10.1074/jbc.274.45.31751, 10542193.
5. Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 2008, 70:431-457. 10.1146/annurev.physiol.70.113006.100659, 17850209.
6. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006, 16:467-476. 10.1016/j.tcb.2006.07.006, 16904320.
7. Carraway KL, Funes M, Workman HC, Sweeney C. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr Top Dev Biol 2007, 78:1-22. full_text, 17338913.
8. Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. FASEB J 2008, 22:966-981. 10.1096/fj.07-9673rev, 18024835.
9. Carraway KL, Rossi EA, Komatsu M, Price-Schiavi SA, Huang D, Guy PM, Carvajal ME, Fregien N, Carraway CA, Carraway KL. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J Biol Chem 1999, 274:5263-5266. 10.1074/jbc.274.9.5263, 10026131.
10. Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CA. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 2002, 71:149-185. full_text, 12102554.
11. Funes M, Miller JK, Lai C, Carraway KL, Sweeney C. The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3. J Biol Chem 2006, 281:19310-19319. 10.1074/jbc.M603225200, 16690615.
12. Workman HC, Sweeney C, Carraway KL. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res 2009, 69:2845-2852. 10.1158/0008-5472.CAN-08-2089, 19293191.
13. Croce MV, Isla-Larrain M, Rabassa ME, Demichelis S, Colussi AG, Crespo M, Lacunza E, Segal-Eiras A. Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision. Pathol Oncol Res 2007, 13:130-138. 10.1007/BF02893488, 17607374.
14. Welsch U, Oppermann T, Mortezza M, Hofter E, Unterberger P. Secretory phenomena in the non-lactating human mammary gland. Ann Anat 2007, 189:131-141. 10.1016/j.aanat.2006.09.010, 17419546.
15. Kwon KY, Ro JY, Singhal N, Killen DE, Sienko A, Allen TC, Zander DS, Barrios R, Haque A, Cagle PT. MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. Arch Pathol Lab Med 2007, 131:593-598.
16. Theodoropoulos G, Carraway CA, Carraway KL. MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury. J Cell Biochem 2009, 107:112-122. 10.1002/jcb.22106, 19288496.
17. Giuntoli RLII, Rodriguez GC, Whitaker RS, Dodge R, Voynow JA. Mucin gene expression in ovarian cancers. Cancer Res 1998, 58:5546-5550.
18. Davidson B, Baekelandt M, Shih I. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Diagn Cytopathol 2007, 35:756-760. 10.1002/dc.20771, 18008338.
19. Karg A, Dinc ZA, Basok O, Ucvet A. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC). Pathol Res Pract 2006, 202:577-583. 10.1016/j.prp.2006.04.002, 16814944.
20. Choudhury A, Moniaux N, Winpenny JP, Hollingsworth MA, Aubert JP, Batra SK. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem 2000, 128:233-243.
21. Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T, Osako M, Takao S, Batra SK, Aikou T, Imai K, Yonezawa S. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol 2005, 58:845-852. 10.1136/jcp.2004.023572, 1770880, 16049287.
22. Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Taki R, Ohkohchi N, Hyodo I, Thomas MB, Krishnamurthy S, Carraway KL, Irimura T. MUC4 interacts with ErbB2 in human gallbladder carcinoma: Potential pathobiological implications. Eur J Cancer 2008, 44:1048-1056. 10.1016/j.ejca.2008.03.007, 18397823.
23. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005, 18:1295-1304. 10.1038/modpathol.3800445, 15976813.
24. Komatsu M, Carraway CA, Fregien NL, Carraway KL. Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J Biol Chem 1997, 272:33245-33254. 10.1074/jbc.272.52.33245, 9407114.
25. Komatsu M, Jepson S, Arango ME, Carothers Carraway CA, Carraway KL. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 2001, 20:461-470. 10.1038/sj.onc.1204106, 11313977.
26. Komatsu M, Tatum L, Altman NH, Carothers Carraway CA, Carraway KL. Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional anti-adhesive glycoprotein. Int J Cancer 2000, 87:480-486. 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6, 10918186.
27. Tanner M, Kapanen AI, Junttila T, Raheem O, Grenman S, Elo J, Elenius K, Isola J. Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol Cancer Ther 2004, 3:1585-1592.
28. Rossi EA, McNeer RR, Price-Schiavi SA, Brande JM, Komatsu M, Thompson JF, Carraway CA, Fregien NL, Carraway KL. Sialomucin complex, a heterodimeric glycoprotein complex. Expression as a soluble, secretable form in lactating mammary gland and colon. J Biol Chem 1996, 271:33476-33485. 10.1074/jbc.271.11.5976, 8969211.
29. Nagy P, Friedlander E, Tanner M, Kapanen AI, Carraway KL, Isola J, Jovin TM. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Cancer Res 2005, 65:473-482.
30. Moniaux N, Escande F, Batra SK, Porchet N, Laine A, Aubert JP. Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins. Eur J Biochem 2000, 267:4536-4544. 10.1046/j.1432-1327.2000.01504.x, 10880978.
31. Escande F, Lemaitre L, Moniaux N, Batra SK, Aubert JP, Buisine MP. Genomic organization of MUC4 mucin gene. Towards the characterization of splice variants. Eur J Biochem 2002, 269:3637-3644. 10.1046/j.1432-1033.2002.03032.x, 12153560.
32. Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer 2008, 99:949-956. 10.1038/sj.bjc.6604632, 2538752,2538752, 18781152.
33. Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, de Bolos C, Cardesa A. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 2005, 29:806-813. 10.1097/01.pas.0000155856.84553.c9, 15897748.
34. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 2008, 8:3329-3341. 10.1002/pmic.200800040, 18651706.
35. Jepson S, Komatsu M, Haq B, Arango ME, Huang D, Carraway CA, Carraway KL. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 2002, 21:7524-7532. 10.1038/sj.onc.1205970, 12386815.
36. Komatsu M, Yee L, Carraway KL. Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells. Cancer Res 1999, 59:2229-2236.
37. Moniaux N, Andrianifahanana M, Brand RE, Batra SK. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer 2004, 91:1633-1638. 2409950, 15494719.
38. Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 2007, 5:309-320. 10.1158/1541-7786.MCR-06-0353, 17406026.
39. Van Klinken BJ, Dekker J, Buller HA, Einerhand AW. Mucin gene structure and expression: protection vs. adhesion. Am J Physiol 1995, 269:G613-627.
40. Balague C, Gambus G, Carrato C, Porchet N, Aubert JP, Kim YS, Real FX. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 1994, 106:1054-1061.
41. Soto P, Price-Schiavi SA, Carraway KL. SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-beta and interferon-gamma pathways in rat mammary epithelial cells. J Biol Chem 2003, 278:20338-20344. 10.1074/jbc.M301886200, 12668667.
42. Li P, Price-Schiavi SA, Rudland PS, Carraway KL. Sialomucin complex (rat Muc4) transmembrane subunit binds the differentiation marker peanut lectin in the normal rat mammary gland. J Cell Physiol 2001, 186:397-405. 10.1002/1097-4652(2000)9999:999<000::AID-JCP1037>3.0.CO;2-V, 11169979.
43. Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate 2006, 66:421-429. 10.1002/pros.20372, 16302265.